Pfizer unit awarded $108 million for AstraZeneca infringement by Delaware jury
Image from Shutterstock/nitpicker
But big money pharma patent damages have a habit of being overturned
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.
Subscribe now
Already have access? Login below
